RUNX1 and neoplasm: Taken together, miR-30d plays a tumor-suppressive role in resisting pancreatic tumorigenesis via a selective target loss of HK1 and SLC2A1-regulator RUNX1, subsequently resulting in inhibition of the Warburg effect.